One week until our GRAS vs NDI webinar. π
June 9 at 1:00 PM ET. QSS Senior Regulatory Specialist Bryana Hallam breaks down both U.S. ingredient pathways and how to choose the right one. π¬
Still open: https://t.co/PFv4x5RFkO π
#FDACompliance#RegulatoryAffairs
π§ͺ FDA finalized its food chemical safety assessment program on May 12, 2026. BHT and ADA are first up for review. RFIs open until July 13. GRAS substances are within scope.
π https://t.co/KNF4ViTgDa
#FDA#FoodSafety
π FDA updated its OMUFA arrears list on May 11, 2026. FY 2026 facility fees due June 1. Non-payment = public listing + misbranding of OTC products.
π https://t.co/hObppy7OoL
#FDA#OTCDrugs
Choosing the wrong regulatory pathway for your ingredient can mean legal exposure or starting over. Getting it right from the start protects your timeline and your U.S. market entry. Join us June 9 at 1:00 PM ET: https://t.co/oMMUNcsCHD π
#FDACompliance#RegulatoryAffairs
In Ottawa this week for the CHFA Ottawa Regulatory Forum. Good conversations with NNHPD and Health Canada on where the NHP space is heading. A lot in motion right now. π #CHFA#RegulatoryAffairs
GRAS or NDI? The right choice depends on your ingredient. We're breaking it down June 9 at 1:00 PM ET. π―
Reserve spot: https://t.co/sCPgDWCV0Z π
#FDACompliance#GRASCompliance
The FDA is now conducting one-day inspectional assessments across supplements, food, biologics, and medical devices. π¨ Shorter visits, same authority to escalate. Is your facility ready?
π https://t.co/nL6yms1lG3
#FDA#FDAInspections
Health Canada is amending NHP labelling requirements before 2028. πΏ Draft regs targeted for spring 2027. New transition period coming. The June 2028 deadline still stands. π Now is the time to review, not wait.
π https://t.co/T3O71flsYV #HealthCanada#NHP
TBT to Vitafoods Europe π β great connecting with Kevin McIsaac from Inner Armour Sports Nutrition, Lynda Doyle from GRA Nutra, and the team at Enzyme Bioscience. #VitafoodsEurope#Nutraceuticals
GRAS or NDI? The pathway you choose shapes your entire U.S. market entry timeline.
Join QSS's Bryana Hallam on June 9 at 1:00 PM ET to break down both options and how to choose the right one. π¬
Reserve your spot: https://t.co/M5lTOcFTpV π
#FDACompliance#RegulatoryAffairs
Whole ingredient GRAS status does not automatically extend to an extract. π§ͺ The FDA treats them as different substances, and each requires its own safety determination.
π https://t.co/LfYbgLKTmZ
#GRAS#FDA
Andrew's Vitafoods Europe 2025 wrap is live. π¬ Real conversations, real regulatory questions, and we'll be at IFT FIRST in Chicago this July. Connect with us ahead of the show: https://t.co/4Q43Uykuc6 π€
#IFT2026#Vitafoods
Day one at #VitafoodsEurope 2026 in the books. Great energy on the floor and solid conversations with @MartinBauer and LithoLife. If market entry into Canada, the U.S., EU, Australia or the UK is on your radar, let's talk: https://t.co/40EJGlpfV5 π
#RegulatoryCompliance
We're at Vitafoods Europe in Barcelona this week. π Come find us on the floor if you want to talk North American regulatory strategy for supplements, ingredients, or functional foods. π€
π https://t.co/YLLJPX5rOP #Vitafoods2026#RegulatoryAffairs
Health Canada just released its first prebiotic monograph. πΏ Eight ingredients. Specific dosage ranges. Mandatory label requirements. What you need to know before your next NHP submission. π
π https://t.co/8crPciKOa9
#HealthCanada#NHP
Selling cannabis edibles in Canada requires a federal licence, strict THC limits, bilingual plain packaging, and provincial listing approval. π¬ And each step has its own timeline.
π https://t.co/uCQKaurx1Y
#Cannabis#HealthCanada
One week to Vitafoods Europe in Barcelona. π€ QSS works across supplements, functional foods, cosmetics, pet nutrition, and pharma. If North America is your next market, let's connect at the show May 5β7. π
π https://t.co/YLLJPX5rOP #Vitafoods2026#RegulatoryAffairs
Toothpaste in Canada can be a cosmetic, OTC drug, or NHP. π¦· The classification depends on your ingredients and claims, and getting it wrong before packaging is in production is an expensive mistake.
π https://t.co/Bk239qEiLL
#HealthCanada#RegulatoryAffairs
Obesity is a disease under FDA's framework. π Weight loss supplement claims that imply treatment can reclassify your product as a drug. That includes GLP-1 inspired language.
π https://t.co/w39WMBm3xq
#FDA#DietarySupplements